Compliance with drug therapy—new answers to an old question
Open Access
- 1 July 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (7) , 1317-1321
- https://doi.org/10.1093/ndt/16.7.1317
Abstract
Compliance with medical recommendations, especially with drug therapy, has been recognized to represent a complex challenge since its first mentioning by Hippocrates about 2400 years ago [1]. An in‐depth scientific approach towards this problem, however, can only be traced over the past three decades with a strong increase in published studies over this period of time (Figure 1). As is generally true in medicine and other scientific subjects, the availability of reliable methods is of crucial importance for scientific progress. Thus, the development of electronic medication event monitoring systems (MEMS) in 1977 has provided the basis for a rapid expansion in understanding the compliance issue [2]. To date, this method represents the ‘gold standard’ for measuring compliance and its application in many areas of drug research and in clinical practice is rapidly expanding [3,4]. In the following, we will briefly review some of the recent advances in the understanding of medication compliance and will attempt to layout some of the resulting lessons for pharmacotherapy.Keywords
This publication has 19 references indexed in Scilit:
- Noncompliance in organ transplant recipients: a literature reviewGeneral Hospital Psychiatry, 2000
- RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1Transplantation, 2000
- Pharmacoeconomic Impact of Variable CompliancePublished by Wiley ,1999
- The Place of Microelectronic Systems in Measuring CompliancePublished by Wiley ,1999
- Measuring Compliance in Clinical Trials and Ambulatory CarePublished by Wiley ,1999
- Changes in Antihypertensive Therapy - The Role of Adverse Effects and ComplianceBlood Pressure, 1998
- The Electronic Medication Event MonitorClinical Pharmacokinetics, 1997
- The Multilevel Compliance Challenge: Recommendations for a Call to ActionCirculation, 1997
- Role of Patient Compliance in Clinical PharmacokineticsClinical Pharmacokinetics, 1994
- Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA, 1988